Literature DB >> 33690722

Clinical prediction rule for SARS-CoV-2 infection from 116 U.S. emergency departments 2-22-2021.

Jeffrey A Kline1, Carlos A Camargo2, D Mark Courtney3, Christopher Kabrhel2, Kristen E Nordenholz4, Thomas Aufderheide5, Joshua J Baugh2, David G Beiser6, Christopher L Bennett7, Joseph Bledsoe8, Edward Castillo9, Makini Chisolm-Straker10, Elizabeth M Goldberg11, Hans House12, Stacey House13, Timothy Jang14, Stephen C Lim15, Troy E Madsen16, Danielle M McCarthy17, Andrew Meltzer18, Stephen Moore19, Craig Newgard20, Justine Pagenhardt21, Katherine L Pettit1, Michael S Pulia22, Michael A Puskarich23, Lauren T Southerland24, Scott Sparks25, Danielle Turner-Lawrence26, Marie Vrablik27, Alfred Wang1, Anthony J Weekes28, Lauren Westafer29, John Wilburn30.   

Abstract

OBJECTIVES: Accurate and reliable criteria to rapidly estimate the probability of infection with the novel coronavirus-2 that causes the severe acute respiratory syndrome (SARS-CoV-2) and associated disease (COVID-19) remain an urgent unmet need, especially in emergency care. The objective was to derive and validate a clinical prediction score for SARS-CoV-2 infection that uses simple criteria widely available at the point of care.
METHODS: Data came from the registry data from the national REgistry of suspected COVID-19 in EmeRgency care (RECOVER network) comprising 116 hospitals from 25 states in the US. Clinical variables and 30-day outcomes were abstracted from medical records of 19,850 emergency department (ED) patients tested for SARS-CoV-2. The criterion standard for diagnosis of SARS-CoV-2 required a positive molecular test from a swabbed sample or positive antibody testing within 30 days. The prediction score was derived from a 50% random sample (n = 9,925) using unadjusted analysis of 107 candidate variables as a screening step, followed by stepwise forward logistic regression on 72 variables.
RESULTS: Multivariable regression yielded a 13-variable score, which was simplified to a 13-point score: +1 point each for age>50 years, measured temperature>37.5°C, oxygen saturation<95%, Black race, Hispanic or Latino ethnicity, household contact with known or suspected COVID-19, patient reported history of dry cough, anosmia/dysgeusia, myalgias or fever; and -1 point each for White race, no direct contact with infected person, or smoking. In the validation sample (n = 9,975), the probability from logistic regression score produced an area under the receiver operating characteristic curve of 0.80 (95% CI: 0.79-0.81), and this level of accuracy was retained across patients enrolled from the early spring to summer of 2020. In the simplified score, a score of zero produced a sensitivity of 95.6% (94.8-96.3%), specificity of 20.0% (19.0-21.0%), negative likelihood ratio of 0.22 (0.19-0.26). Increasing points on the simplified score predicted higher probability of infection (e.g., >75% probability with +5 or more points).
CONCLUSION: Criteria that are available at the point of care can accurately predict the probability of SARS-CoV-2 infection. These criteria could assist with decisions about isolation and testing at high throughput checkpoints.

Entities:  

Mesh:

Year:  2021        PMID: 33690722      PMCID: PMC7946184          DOI: 10.1371/journal.pone.0248438

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  25 in total

1.  Defining the Epidemiology of Covid-19 - Studies Needed.

Authors:  Marc Lipsitch; David L Swerdlow; Lyn Finelli
Journal:  N Engl J Med       Date:  2020-02-19       Impact factor: 91.245

2.  Prospective multicenter evaluation of the pulmonary embolism rule-out criteria.

Authors:  J A Kline; D M Courtney; C Kabrhel; C L Moore; H A Smithline; M C Plewa; P B Richman; B J O'Neil; K Nordenholz
Journal:  J Thromb Haemost       Date:  2008-03-03       Impact factor: 5.824

3.  Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration.

Authors:  Karel G M Moons; Douglas G Altman; Johannes B Reitsma; John P A Ioannidis; Petra Macaskill; Ewout W Steyerberg; Andrew J Vickers; David F Ransohoff; Gary S Collins
Journal:  Ann Intern Med       Date:  2015-01-06       Impact factor: 25.391

4.  No rationale for 1 variable per 10 events criterion for binary logistic regression analysis.

Authors:  Maarten van Smeden; Joris A H de Groot; Karel G M Moons; Gary S Collins; Douglas G Altman; Marinus J C Eijkemans; Johannes B Reitsma
Journal:  BMC Med Res Methodol       Date:  2016-11-24       Impact factor: 4.615

5.  Similarities and Differences in COVID-19 Awareness, Concern, and Symptoms by Race and Ethnicity in the United States: Cross-Sectional Survey.

Authors:  Jeb Jones; Patrick S Sullivan; Travis H Sanchez; Jodie L Guest; Eric W Hall; Nicole Luisi; Maria Zlotorzynska; Gretchen Wilde; Heather Bradley; Aaron J Siegler
Journal:  J Med Internet Res       Date:  2020-07-10       Impact factor: 5.428

6.  Impact of sample size on the stability of risk scores from clinical prediction models: a case study in cardiovascular disease.

Authors:  Alexander Pate; Richard Emsley; Matthew Sperrin; Glen P Martin; Tjeerd van Staa
Journal:  Diagn Progn Res       Date:  2020-09-09

Review 7.  Pulse Oximetry for Monitoring Patients with COVID-19 at Home. Potential Pitfalls and Practical Guidance.

Authors:  Andrew M Luks; Erik R Swenson
Journal:  Ann Am Thorac Soc       Date:  2020-09

8.  Multicenter registry of United States emergency department patients tested for SARS-CoV-2.

Authors:  Jeffrey A Kline; Katherine L Pettit; Christopher Kabrhel; D Mark Courtney; Kristen E Nordenholz; Carlos A Camargo
Journal:  J Am Coll Emerg Physicians Open       Date:  2020-11-12

9.  Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.

Authors:  Jacqueline Dinnes; Jonathan J Deeks; Ada Adriano; Sarah Berhane; Clare Davenport; Sabine Dittrich; Devy Emperador; Yemisi Takwoingi; Jane Cunningham; Sophie Beese; Janine Dretzke; Lavinia Ferrante di Ruffano; Isobel M Harris; Malcolm J Price; Sian Taylor-Phillips; Lotty Hooft; Mariska Mg Leeflang; René Spijker; Ann Van den Bruel
Journal:  Cochrane Database Syst Rev       Date:  2020-08-26

10.  Ensemble learning model for diagnosing COVID-19 from routine blood tests.

Authors:  Maryam AlJame; Imtiaz Ahmad; Ayyub Imtiaz; Ameer Mohammed
Journal:  Inform Med Unlocked       Date:  2020-10-20
View more
  9 in total

Review 1.  Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.

Authors:  Thomas Struyf; Jonathan J Deeks; Jacqueline Dinnes; Yemisi Takwoingi; Clare Davenport; Mariska Mg Leeflang; René Spijker; Lotty Hooft; Devy Emperador; Julie Domen; Anouk Tans; Stéphanie Janssens; Dakshitha Wickramasinghe; Viktor Lannoy; Sebastiaan R A Horn; Ann Van den Bruel
Journal:  Cochrane Database Syst Rev       Date:  2022-05-20

2.  Lessons from the frontline: The value of emergency care processes and data to pandemic responses across the Pacific region.

Authors:  Rob Mitchell; Gerard O'Reilly; Lisa-Maree Herron; Georgina Phillips; Deepak Sharma; Claire E Brolan; Sarah Körver; Mangu Kendino; Penisimani Poloniati; Berlin Kafoa; Megan Cox
Journal:  Lancet Reg Health West Pac       Date:  2022-07-06

3.  Multicenter Study of Outcomes Among Persons With HIV Who Presented to US Emergency Departments With Suspected SARS-CoV-2.

Authors:  Christopher L Bennett; Emmanuel Ogele; Nicholas R Pettit; Jason J Bischof; Tong Meng; Prasanthi Govindarajan; Carlos A Camargo; Kristen Nordenholz; Jeffrey A Kline
Journal:  J Acquir Immune Defic Syndr       Date:  2021-12-01       Impact factor: 3.771

4.  External validation of the 4C Mortality Score for hospitalised patients with COVID-19 in the RECOVER network.

Authors:  Alexandra June Gordon; Prasanthi Govindarajan; Christopher L Bennett; Loretta Matheson; Michael A Kohn; Carlos Camargo; Jeffrey Kline
Journal:  BMJ Open       Date:  2022-04-21       Impact factor: 3.006

5.  Predicting 30-day return hospital admissions in patients with COVID-19 discharged from the emergency department: A national retrospective cohort study.

Authors:  David G Beiser; Zachary J Jarou; Alaa A Kassir; Michael A Puskarich; Marie C Vrablik; Elizabeth D Rosenman; Samuel A McDonald; Andrew C Meltzer; D Mark Courtney; Christopher Kabrhel; Jeffrey A Kline
Journal:  J Am Coll Emerg Physicians Open       Date:  2021-12-29

6.  A 12-hospital prospective evaluation of a clinical decision support prognostic algorithm based on logistic regression as a form of machine learning to facilitate decision making for patients with suspected COVID-19.

Authors:  Monica I Lupei; Danni Li; Nicholas E Ingraham; Karyn D Baum; Bradley Benson; Michael Puskarich; David Milbrandt; Genevieve B Melton; Daren Scheppmann; Michael G Usher; Christopher J Tignanelli
Journal:  PLoS One       Date:  2022-01-05       Impact factor: 3.752

7.  CCEDRRN COVID-19 Infection Score (CCIS): development and validation in a Canadian cohort of a clinical risk score to predict SARS-CoV-2 infection in patients presenting to the emergency department with suspected COVID-19.

Authors:  Andrew D McRae; Corinne M Hohl; Rhonda Rosychuk; Shabnam Vatanpour; Gelareh Ghaderi; Patrick M Archambault; Steven C Brooks; Ivy Cheng; Philip Davis; Jake Hayward; Eddy Lang; Robert Ohle; Brian Rowe; Michelle Welsford; Krishan Yadav; Laurie J Morrison; Jeffrey Perry
Journal:  BMJ Open       Date:  2021-12-02       Impact factor: 2.692

8.  Should COVID-19 symptoms be used to cohort patients in the emergency department? A retrospective analysis.

Authors:  Polly E Bijur; Benjamin W Friedman; Sarah W Baron; Abhiram Ramasahayam; Rebecca Nerenberg; Shellyann Sharpe; D Yitzchak Goldstein; David Esses
Journal:  Am J Emerg Med       Date:  2022-02-06       Impact factor: 4.093

9.  Age-related differences in symptoms in older emergency department patients with COVID-19: Prevalence and outcomes in a multicenter cohort.

Authors:  Elizabeth M Goldberg; Lauren T Southerland; Andrew C Meltzer; Justine Pagenhardt; Ryan Hoopes; Carlos A Camargo; Jeffrey A Kline
Journal:  J Am Geriatr Soc       Date:  2022-04-29       Impact factor: 7.538

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.